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S276 Poster Session Iprior to AlloSCT but none with evidence of LLM at the time of
AlloSCT. Two patients experienced Grade II-III headache. Grade
II-III vomiting was also noted in 2 additional patients. Seven patients
developed relapsed systemic disease but none of them had CNS AL/
NHL at time of death.
Conclusion: These preliminary results suggest that prophylactic li-
posomal cytarabine is tolerable and effective in pediatric AlloSCT
and AutoSCT recipients at risk for CNS relapse. Larger studies
are needed in the future to compare this to other CNS prophylaxis
regimens post auto or AlloSCT.
196
G-CSF MOBILIZATION ALONE, A SHORTER DURATION OF NEUTROPENIA,
AND THE RAPIDITY OF ENGRAFTMENT ARE ASSOCIATED WITH EN-
GRAFTMENT SYNDROME IN PATIENTS UNDERGOING AUTOLOGOUS
PBSCT FOR MULTIPLE MYELOMA
Burnette, B.1, Dispenzieri, A.1, Porrata, L.1, Hogan, W.1, Holtan, S.2
1Mayo Clinic Foundation, Rochester, MN; 2Oregon Health Sciences Uni-
versity, Portland, OR
Introduction: Maiolino in 2003 proposed criteria for Engraftment
Syndrome (ES). Criteria included non infectious fever plus one (or
more) of the following: rash, pulmonary infiltrates, or diarrhea. Clin-
ical practice has since shifted. In the Maiolino series all patients were
mobilized with cyclophosphamide (CTX) andG-CSF, while current
options include G-CSF, G-CSF plus plerixafor, or CTX with
G-CSF. Patients were also treated with G-CSF in the early trans-
plant period. We felt it appropriate to assess our experience with
ES in modern patients with multiple myeloma.
Methods: After IRB approval, the Mayo Clinic BMT Database was
queried for all patients between 1/1/2009 and 12/31/2009 whom un-
derwent autologous PBSCT for multiple myeloma. Patient records
were accessed to assess the rate of non-infectious fever, engraftment
syndrome, time to engraftment, rapidity of engraftment, mobiliza-
tion regimens, and demographic information. Criteria for ES in-
cluded non-infectious fever occurring up to 5 days prior to
ANC.500 plus rash, diarrhea or significant worsening of prior diar-
rhea, or pulmonary decline (defined as new oxygen requirement, in-
creased oxygen requirement, pulmonary infiltrates, or new
tachypnea .20).
Results: 112 patients were identified. All patients received G-CSF
for mobilization. 51 (46%) received G-CSF alone, 45 (40%) with
CTX (1.5 gm/m2 daily for two days), 23 (20%) with plerixafor, 3
(2.6%) with both G-CSF and CTX, and one during recovery from
chemotherapy (VDT-PACE). Two patient received G-CSF in the
early transplant period on a clinical trial. Eighteen patients (16%)
met our criteria for ES. The relative risk of conditioning with G-
CSF alone was 3.1 (95% CI 1.1-9.6). Median time from WBC 500
to ANC 1000 was 3d (0-5) and 4d (0-14) with and without ES
(p 5 .004). Median duration of neutropenia was 8d (7-14) and 10d
(5-18) with and without ES (p 5 0.02). One patient with non-
infectious fever and increased oxygen requirement experienced sud-
den death soon after hospital admission onD+8, felt to be potentially
attributable to ES.
Discussion: Our data confirm a similar incidence of ES as that de-
scribed by Maiolino. For the first time, we have also demonstrated
an association between G-CSF mobilization alone, rapidity of en-
graftment, and duration of neutropenia with the clinical diagnosis
of ES. It is speculated that the composition of the autologous stem
cell product may differ with mobilization regimens currently utilized
in clinical practice.
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DOUBLE CORD BLOOD TRANSPLANTATION: PRE-ENGRAFTMENT OR
RECESSIVE CORD REJECTION SYNDROME?
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Pre-engraftment syndrome (PES) is a mechanistically poorly
understood clinical syndrome essentially characterized by fever and
erythematous skin rash with no infectious process and which occurs
shortly before neutrophil recovery after double cord blood trans-
plantation. The syndrome promptly responds to small doses of ste-
roids. Similar clinical syndrome has been described with rejectionof mismatched hematopoietic stem cells. Herein, we provide prelim-
inary post-chimerism data suggesting that the syndrome is concom-
itant with the disappearance of one of the two infused cords and
possibly indeed due to the rejection of one of the cords as opposed
to engraftment.
Three patients underwent double cord blood transplantation us-
ing a conditioning regimen combining cyclophosphamide, fludara-
bine and total body irradiation for primary myelofibrosis, acute
myeloid leukemia and chronic myeloid leukemia in blast crisis.
Patients 1 and 3 received myeloabaltive conditioning while patient
2 received non-myeloablative treatment. All three patients showed
unexplained fever and erythematous skin rash on days +13, +20,
and +12 respectively. All three patients rapidly responded to small
doses of steroids. Post-chimerism studies on the first patient on
day +12 showed 46% non patient DNA with both cords equally rep-
resented. A repeat study on day +19 showed 56% non patient DNA
with only one cord detected. Post-chimerism studies on the second
patient on day +22, when the clinical syndrome was present, showed
86% non patient DNA with both cords present while the same
studies done on the third patient on day +17 after resolution of the
syndrome showed only non patient DNA derived from one cord.
In summary, we showed some preliminary post-chimerism studies
on patients with double cord blood transplantation with PES sug-
gesting that the syndrome rather corresponds to rejection of one
of the cords. The data is supported by the fact that the syndrome
was described after double cord transplants and the similarity of
the syndrome with the rejection syndrome observed after infusion
of mismatched hematopoietic stem cells. Therefore, we suggest fur-
ther studies to elucidate the mechanism of the syndrome and suggest
rather the name of recessive cord rejection syndrome or RCRS.
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Introduction:The aim of hematopoietic progenitor cell transplants
(HPCT) is to implant a healthy system in the place of an unhealthy
one. Total immunological recovery is a slow process and often after
the transplant remains incomplete. Although the reconstitution of
innate immunity is fast, adaptive immunity is seen to be compro-
mised for years, especially in lymphopoiesis of B and T cells. Present
study compare the immune recontitution in pediatric patients post-
transplanted with 3 different types of hematopoietic progenitor cells
from 2008 – 2010. In the National Institute of Pediatrics, Mexico.
Materials and Method: 31 patients (12 females and 19 males) who
were subjected to hematopoietic progenitor cell transplants in bone
marrow transplantation unit in Pediatrics National Institute (INP)
were recruited for the study. The study is retrospective. Autologous
transplant was carried out in 2 of the patients while allogenic trans-
plant was done in 29 of them. According to our data source, 14 of the
transplants were with umbilical cord cells and 17 with peripheral
blood. Subpopulation post-transplant follow-up was carried out by
means of flow cytometry using surface monoclonal antibodies:
CD3, CD4, CD8, CD19, and CD56 for 3, 6, 9, and 12 months.
Results: All the patients showed similar tendency. It was observed
that cells with CD3 immunophenotype presented normal values
from the beginning at the expense of adequate values of CD8, while
the values of CD4 remained low all through the follow-up. There is
significant statistical difference between the numbers of CD3 in pe-
ripheral blood compared with that of the umbilical cord at 3 months.
CD4/CD8 index was found with normal values from the beginning
and throughout the follow-up while the absolute values of CD19 and
CD56 cell immunophenotypes were found below normal in all the
detections.
Conclusion: From the data obtained in the lymphocyte sub-popula-
tionsmeasurement, incomplete immunological reconstitution at one
year was observed not only in peripheral blood but also in umbilical
cord. However, we suggest that further studies involving higher
number of cases is need to establish a definitive reconstitution
pattern.
